Vaccinex Files 8-K on Security Holder Rights, Bylaw Changes

TL;DR

**Vaccinex filed an 8-K on February 15, 2024, reporting changes to security holder rights and company bylaws that occurred on February 14, 2024.**

AI Summary

Vaccinex, Inc. filed an 8-K on February 15, 2024, reporting events that occurred on February 14, 2024. The filing indicates material modifications to the rights of its security holders and amendments to its Articles of Incorporation or Bylaws. The report also covers other events and includes financial statements and exhibits.

Why It Matters

Changes to security holder rights and company bylaws can significantly alter investor control, voting power, and the company's operational framework, potentially impacting future corporate actions and shareholder value.

Risk Assessment

Risk Level: medium — Modifications to security holder rights and company bylaws can introduce new risks or opportunities, altering the investment landscape for shareholders.

Key Players & Entities

• VACCINEX, INC. (company) — filer
• 001-38624 (other) — Commission File Number
• 16-1603202 (other) — IRS Employer Identification No.
• Delaware (other) — State of Incorporation
• Rochester (other) — City of Business Address
• New York (other) — State of Business Address

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock, par value $0.0001 per share VCNX Nasdaq Capital Marke

Filing Documents

• d754295d8k.htm (8-K) — 31KB
• d754295dex31.htm (EX-3.1) — 9KB
• d754295dex991.htm (EX-99.1) — 12KB
• g754295page8.jpg (GRAPHIC) — 9KB
• 0001193125-24-037078.txt ( ) — 197KB
• vcnx-20240214.xsd (EX-101.SCH) — 3KB
• vcnx-20240214_lab.xml (EX-101.LAB) — 18KB
• vcnx-20240214_pre.xml (EX-101.PRE) — 11KB
• d754295d8k_htm.xml (XML) — 4KB

Forward Looking Statements

Forward Looking Statements Except for the factual statements made herein, information contained in this report consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that are difficult to predict. Words such as "will," "may," "intends," "plans," and similar expressions, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Such forward-looking statements are not guarantees of performance and actual actions or events could differ materially from those contained in such statements. For example, there can be no assurance that the Company will be able to regain compliance with the Nasdaq Listing standards. The risks included are not exhaustive; for a more detailed description of these uncertainties and other factors, see the other risk factors set forth from time to time in the Company's filings with the Securities and Exchange Commission, copies of which are available for free at www.sec.gov or upon request from the Company's Investor Relations Department. All information provided in this Form 8-K is as of the date hereof and the Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law. Item9.01

Financial Statements and Exhibits

Financial Statements and Exhibits. Exhibit No. Description 3.1 Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Vaccinex, Inc., effective as of February 19, 2024 99.1 Press Release, dated February 15, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VACCINEX, INC. Date: February 15, 2024 By: /s/ Scott E. Royer Scott E. Royer Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR